Home / Market News / $ISRG

$ISRG news and market catalysts

The 50 most recent market catalysts affecting $ISRG, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

50 catalysts 12 high impact 11 bullish 33 bearish Medical Technology
Nov 18, 2026 Corporate Catalyst Bullish Impact 55
BTIG Adjusts Price Target on Intuitive Surgical to $513 From $454
BTIG, an analyst firm, adjusted its price target for Intuitive Surgical (ISRG) from $454 to $513. This action reflects a revised and more favorable valuation outlook for the medica…
Nov 10, 2026 Corporate Catalyst Bullish Impact 55
BofA Securities Maintains Intuitive Surgical With Buy Rating, Raises Price Target to $500
BofA Securities analyst Travis Steed has maintained a 'Buy' rating on Intuitive Surgical (ISRG) and raised the price target from $470 to $500. This action reflects a positive outlo…
Nov 2, 2026 Corporate Catalyst Neutral Impact 55
Intuitive Surgical Appoints Aaron Martin to Board of Directors
Intuitive Surgical is bringing Aaron Martin, a seasoned executive with deep experience in healthcare technology, digital innovation, and health system leadership, onto its board of…
Oct 27, 2026 Corporate Catalyst Bullish Impact 65
Daiwa Securities Adjusts Price Target on Intuitive Surgical to $490 From $360
Daiwa Securities has raised its price target for Intuitive Surgical (ISRG) from $360 to $490, indicating a substantially more bullish stance on the company's prospects. This analys…
Oct 23, 2026 Corporate Catalyst Bullish Impact 55
Rothschild & Co Redburn Adjusts Price Target on Intuitive Surgical to $560 From $540
Rothschild & Co Redburn, a financial services firm, has raised its price target for Intuitive Surgical (ISRG) from $540 to $560. This indicates an improved outlook on the company's…
Oct 22, 2026 Corporate Catalyst Bullish Impact 55
Barclays Adjusts Intuitive Surgical Price Target to $500
Barclays analyst Christopher Pasquale raised the price target for Intuitive Surgical (ISRG) from $485 to $500, while reiterating a Buy rating. This action indicates an updated posi…
Oct 22, 2026 Corporate Catalyst Bearish Impact 85
Intuitive Surgical Stock Declines Following 2026 Growth Outlook Adjustment and $450 Million Charge
Intuitive Surgical's stock declined after the company adjusted its 2026 growth outlook for its flagship da Vinci surgical system and disclosed a $450 million charge affecting its t…
Oct 22, 2026 Corporate Catalyst Bearish Impact 65
Intuitive Surgical Faces Potential 2027 Procedure Momentum Risks from Pricing Actions, RBC Says
RBC Capital Markets has identified that Intuitive Surgical's recent pricing actions could create headwinds for its procedure growth momentum leading into 2027. This matters because…
Oct 21, 2026 Corporate Catalyst Bearish Impact 55
RBC Capital Maintains Outperform on Intuitive Surgical, Lowers Price Target to $550
RBC Capital's analyst Kendall Au maintained an 'Outperform' rating on Intuitive Surgical (ISRG), signaling continued confidence in the company's long-term prospects. However, the p…
Oct 21, 2026 Corporate Catalyst Bearish Impact 55
Mizuho Maintains Neutral on Intuitive Surgical, Lowers Price Target to $400
Mizuho analyst Anthony Petrone maintained a 'Neutral' rating on Intuitive Surgical (ISRG) but lowered the price target from $415 to $400. This action reflects a slightly less optim…
Oct 21, 2026 Corporate Catalyst Bearish Impact 75
Intuitive Surgical shares are trading lower after the company reported a year-over-year decrease in Q3 GAAP EPS and growing non-GAAP FY26 operating expenses. The company's one-time $450 million settlement payment, which impacts GAAP net income, remains subject to preliminary and final court approval.
This headline indicates a significant negative catalyst for Intuitive Surgical. The year-over-year decrease in GAAP EPS, coupled with growing non-GAAP operating expenses for FY26, …
Oct 21, 2026 Corporate Catalyst Bullish Impact 55
Baird Maintains Outperform on Intuitive Surgical, Raises Price Target to $550
Baird analyst David Rescott has maintained an 'Outperform' rating on Intuitive Surgical (ISRG) and raised the price target from $513 to $550. This action signals continued confiden…
Oct 20, 2026 Corporate Catalyst Neutral Impact 65
Intuitive Surgical Executive Says Estimated Tariff Impact On 2026 Non-GAAP Gross Margin Now 90 Basis Points
Intuitive Surgical's executive revealed during a conference call that the estimated tariff impact on the company's 2026 non-GAAP gross margin is now 90 basis points. This is a spec…
Oct 20, 2026 Corporate Catalyst Bearish Impact 92
Intuitive Surgical Tops Q3 Estimates, Shares Tumble
Intuitive Surgical delivered a strong third quarter, surpassing analyst expectations for both revenue and earnings per share, fueled by robust growth in surgical procedures and sys…
Oct 20, 2026 Corporate Catalyst Bearish Impact 85
Intuitive Surgical shares are trading lower after the company reported a year-over-year decrease in Q3 GAAP EPS and growing non-GAAP FY26 operating expenses. The company's one-time $450 million settlement payment, which impacts GAAP net income, remains subject to preliminary and final court approval.
The headline indicates a significant negative corporate catalyst for Intuitive Surgical. The year-over-year decrease in Q3 GAAP EPS, coupled with growing non-GAAP FY26 operating ex…
Oct 20, 2026 Corporate Catalyst Bullish Impact 75
Intuitive Surgical Forecasts 14% - 15% Da Vinci Procedure Growth In 2026; 68.7% – 69.3% Gross Margin And 11%–13% Operating Expense Growth
Intuitive Surgical (ISRG) released its 2026 financial outlook, forecasting 14%-15% worldwide da Vinci procedure growth, a non-GAAP gross profit margin of 68.7%-69.3%, and non-GAAP …
Oct 20, 2026 Corporate Catalyst Bullish Impact 95
Intuitive Surgical Q3 Adj. EPS $3.00 Beats $2.64 Estimate, Sales $3.049B Beat $2.906B Estimate
Intuitive Surgical (ISRG) announced impressive Q3 earnings, with adjusted EPS of $3.00 significantly surpassing the $2.64 estimate and sales of $3.049 billion exceeding the $2.906 …
Oct 7, 2026 Corporate Catalyst Neutral Impact 65
Barclays Initiates Coverage On Intuitive Surgical with Overweight Rating, Announces Price Target of $485
Barclays initiating coverage on Intuitive Surgical (ISRG) with an 'Overweight' rating and a $485 price target is a positive development for the company. Analyst coverage, especiall…
Sep 30, 2026 Corporate Catalyst Neutral Impact 65
Move Over Tesla: Intuitive Surgical Shows Why Robotics Could Be Bigger Than Humanoids
This filing discloses RoboStrategy CEO Andrew Kang's perspective on the robotics investment landscape, highlighting a divergence in valuations between general-purpose humanoids and…
Sep 9, 2026 Corporate Catalyst Bearish Impact 75
Intuitive Surgical Executive Says The Company's U.S. Business, Accounting For ~60% Of Its Operations, Is Decelerating; Company's Growth Drivers Expected To Remain Broadly Consistent In 2026 YoY
Intuitive Surgical's executive commentary on a conference call revealed a deceleration in its U.S. business, which is a significant concern given it accounts for 60% of the company…
Sep 8, 2026 Corporate Catalyst Neutral Impact 55
Intuitive Surgical Published Systematic Review And Meta-Analysis In Peer-Reviewed Annals Of Surgery Open.
This headline indicates a positive corporate catalyst for Intuitive Surgical (ISRG). The publication of a systematic review and meta-analysis in a peer-reviewed journal like Annals…
Aug 12, 2026 Corporate Catalyst Bullish Impact 75
Oppenheimer Upgrades Intuitive Surgical to Outperform, Announces $500 Price Target
Oppenheimer analyst Suraj Kalia upgraded Intuitive Surgical (ISRG) from a 'Perform' rating to an 'Outperform' rating, simultaneously establishing a $500 price target. This upgrade …
Jul 30, 2026 Corporate Catalyst Bearish Impact 65
HSBC Downgrades Intuitive Surgical to Hold, Announces $931 Price Target
HSBC analyst Helen Fang downgraded Intuitive Surgical (ISRG) from a 'Buy' to a 'Hold' rating, simultaneously announcing a $931 price target. This action signals a more tempered out…
Jul 17, 2026 Corporate Catalyst Bearish Impact 55
Raymond James Maintains Outperform on Intuitive Surgical, Lowers Price Target to $483
Raymond James analyst Jayson Bedford maintained an 'Outperform' rating on Intuitive Surgical (ISRG) but significantly lowered the price target from $577 to $483. This action signal…
Jul 17, 2026 Corporate Catalyst Bearish Impact 95
Intuitive Surgical Stock Sinks to 52-Week Low - Here's Why
Intuitive Surgical (ISRG) experienced a sharp decline in its stock price due to several converging headwinds. The company reported a moderation in U.S. procedure growth, particular…
Jul 17, 2026 Corporate Catalyst Bearish Impact 65
Piper Sandler Reiterates Overweight on Intuitive Surgical, Lowers Price Target to $470
Piper Sandler's decision to lower Intuitive Surgical's price target by $110, from $580 to $470, despite maintaining an 'Overweight' rating, indicates a recalibration of valuation e…
Jul 17, 2026 Corporate Catalyst Bearish Impact 75
Shares of medical device companies are trading lower amid sympathy with Intuitive Surgical after the company reported Q2 financial results and noted that the China market remains a challenge. Also, multiple analysts lowered their respective price targets on ISRG.
This headline indicates a significant negative catalyst for the medical device sector. Intuitive Surgical's poor Q2 performance, particularly the challenges in the crucial China ma…
Jul 17, 2026 Corporate Catalyst Bearish Impact 65
JP Morgan Maintains Overweight on Intuitive Surgical, Lowers Price Target to $450
JP Morgan's analyst Robbie Marcus maintained an 'Overweight' rating on Intuitive Surgical, suggesting a continued positive long-term outlook for the company. However, the substanti…
Jul 17, 2026 Corporate Catalyst Bearish Impact 60
Mizuho Maintains Neutral on Intuitive Surgical, Lowers Price Target to $400
Mizuho analyst Anthony Petrone maintained a 'Neutral' rating on Intuitive Surgical (ISRG) but notably lowered the price target from $500 to $400. This action signals a more cautiou…
Jul 17, 2026 Corporate Catalyst Bearish Impact 65
Wells Fargo Maintains Overweight on Intuitive Surgical, Lowers Price Target to $487
Wells Fargo analyst Larry Biegelsen maintained an 'Overweight' rating on Intuitive Surgical (ISRG), indicating a continued positive long-term outlook for the company. However, the …
Jul 17, 2026 Corporate Catalyst Bearish Impact 55
Stifel Maintains Buy on Intuitive Surgical, Lowers Price Target to $550
Stifel's decision to maintain a 'Buy' rating while simultaneously lowering the price target for Intuitive Surgical (ISRG) from $670 to $550 signals a nuanced shift in analyst senti…
Jul 17, 2026 Corporate Catalyst Bearish Impact 92
Intuitive Surgical, Netflix And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
The filing indicates a significant negative sentiment in the pre-market, primarily due to disappointing corporate results and outlooks. Intuitive Surgical, despite beating analyst …
Jul 17, 2026 Corporate Catalyst Bearish Impact 55
Bernstein Maintains Outperform on Intuitive Surgical, Lowers Price Target to $685
Bernstein analyst Lee Hambright maintained an 'Outperform' rating on Intuitive Surgical (ISRG), signaling continued confidence in the company's long-term prospects. However, the pr…
Jul 17, 2026 Corporate Catalyst Bearish Impact 65
Leerink Partners Maintains Outperform on Intuitive Surgical, Lowers Price Target to $454
Leerink Partners, through analyst Mike Kratky, maintained an 'Outperform' rating on Intuitive Surgical (ISRG), indicating a continued belief in the company's long-term prospects. H…
Jul 17, 2026 Corporate Catalyst Bearish Impact 85
Why Is Intuitive Surgical Stock Sinking Friday?
Intuitive Surgical (ISRG) saw its stock plummet despite beating Q2 earnings and revenue estimates. The market reacted negatively to the company's decision to reaffirm its 2026 da V…
Jul 17, 2026 Corporate Catalyst Bearish Impact 75
Intuitive Surgical shares are trading lower after the company reported Q2 financial results and during a conference call, an executive said that the China environment remains a challenge. BTIG and Baird lowered their respective price targets on the stock.
The headline highlights a direct corporate catalyst: Intuitive Surgical's Q2 earnings report and subsequent executive commentary. The negative sentiment stems from the 'China envir…
Jul 17, 2026 Corporate Catalyst Bearish Impact 85
These Analysts Slash Their Forecasts On Intuitive Surgical Following Q2 Earnings
Intuitive Surgical (ISRG) announced Q2 earnings and revenue that surpassed analyst consensus estimates. However, the stock experienced an 11.1% drop in pre-market trading, suggesti…
Jul 17, 2026 Corporate Catalyst Bearish Impact 55
Baird Maintains Outperform on Intuitive Surgical, Lowers Price Target to $500
Baird analyst David Rescott maintained an 'Outperform' rating on Intuitive Surgical (ISRG) but lowered the price target from $525 to $500. This action signals a slight reduction in…
Jul 17, 2026 Corporate Catalyst Bearish Impact 55
BTIG Maintains Buy on Intuitive Surgical, Lowers Price Target to $469
BTIG analyst Ryan Zimmerman maintained a 'Buy' rating on Intuitive Surgical (ISRG), signaling continued confidence in the company's long-term prospects. However, the price target w…
Jul 16, 2026 Corporate Catalyst Neutral Impact 85
Transcript: Intuitive Surgical Q2 2026 Earnings Conference Call
Intuitive Surgical's Q2 2026 earnings call transcript reveals a robust financial performance with a 19% increase in revenue and 16% growth in total procedures. This indicates stron…
Jul 16, 2026 Market Technicals Bullish Impact 55
12 Health Care Stocks Moving In Thursday's After-Market Session
This filing highlights after-market trading activity for a selection of healthcare stocks, indicating volatility outside of regular trading hours. The movements are largely company…
Jul 16, 2026 Corporate Catalyst Bearish Impact 65
Intuitive Surgical Exec Says China Environment Remains Challenging; Continues To See Increased Domestic Robotic Competition And Policy-Driven Pricing Pressure
During a conference call, an Intuitive Surgical executive highlighted persistent difficulties in the Chinese market, specifically citing heightened domestic competition in robotic …
Jul 16, 2026 Corporate Catalyst Bearish Impact 90
Intuitive Surgical Stock Falls Despite Q2 Earnings Beat
Intuitive Surgical (ISRG) announced impressive Q2 2026 results, surpassing analyst expectations for both EPS and revenue, driven by robust growth in da Vinci and Ion procedures and…
Jul 16, 2026 Corporate Catalyst Bearish Impact 85
Intuitive Surgical shares are trading lower. The company reported Q2 financial results.
The headline indicates a direct corporate catalyst: Intuitive Surgical's Q2 earnings. The immediate negative share price reaction suggests the results likely missed analyst estimat…
Jul 16, 2026 Corporate Catalyst Bullish Impact 92
Intuitive Surgical Q2 Adj. EPS $2.80 Beats $2.50 Estimate, Sales $2.892B Beat $2.820B Estimate
Intuitive Surgical (ISRG) announced Q2 adjusted EPS of $2.80, surpassing the $2.50 consensus estimate by 12%, and sales of $2.892 billion, beating the $2.820 billion estimate by 2.…
Jul 16, 2026 Corporate Catalyst Bearish Impact 55
Truist Securities Maintains Buy on Intuitive Surgical, Lowers Price Target to $510
Truist Securities analyst Richard Newitter lowered the price target for Intuitive Surgical (ISRG) from $580 to $510, while maintaining a 'Buy' rating. This action suggests that whi…
Jul 15, 2026 Corporate Catalyst Bearish Impact 55
Mizuho Maintains Neutral on Intuitive Surgical, Lowers Price Target to $500
Mizuho analyst Anthony Petrone has adjusted Intuitive Surgical's (ISRG) price target downwards from $525 to $500, while keeping a 'Neutral' rating. This action signals a slightly r…
Jul 14, 2026 Corporate Catalyst Bearish Impact 75
Intuitive Surgical Stock Hits 52-Week Lows: What's Going On?
Intuitive Surgical (ISRG) shares have plummeted to a 52-week low, primarily driven by a broader medical device sector downturn following HCA Healthcare's warning about declining su…
Jul 13, 2026 Corporate Catalyst Bearish Impact 65
TD Cowen Maintains Buy on Intuitive Surgical, Lowers Price Target to $520
TD Cowen analyst Mathew Blackman has adjusted their price target for Intuitive Surgical (ISRG) from $585 to $520, although they continue to recommend a 'Buy' rating. This action in…
Jul 13, 2026 Corporate Catalyst Bearish Impact 55
RBC Capital Maintains Outperform on Intuitive Surgical, Lowers Price Target to $600
RBC Capital analyst Shagun Singh maintained an 'Outperform' rating on Intuitive Surgical (ISRG), signaling continued confidence in the company's fundamentals and long-term growth p…
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.